|
|
|
August 15, 2012
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| RSVP Now | |
Featuring presentation on
Bioscience Regions in the U.S. Trends, Best Practices and Competitive Strategies
by
Mitch Horowitz, Managing Director
Battelle Technology Partnership
| |
|
| Reserve Your Spot | |
We Are Determined to Make Your
Participation Memorable
Hit a Hole in One, Win a Toyota Prius C
For details, call SoCalBio at 800-418-7079 or send email at scbc@socalbio.org
|
| SoCalBio W3 Mixer | |
Thanks to Participants in the SoCalBio
W3 Mixer on August 9
| |
|
| Biotech Jobs |
 Top Ten Biotech Jobs Most in Demand Over The Next Decade
Click here to see the list of Jobs in demand based on statistics from the U.S. Bureau of Labor Statistics |
| IPO Market |
Brace Yourself: Biotech IPOs Are
Beating Tech's Big Names
 Luke Timmerman of Xconomy contends: " There's something that might surprise both biotech insiders and the average guy or gal on the street. The biotech IPO class of 2012 has made money for investors, while tech's most glamorous up-and-comers have been stumbling" ... Read more
|
| Venture Capital |
California's Pension Giant CalPERS Appears Ready To Abandon Most VCs
 Venture capital has wallowed through nearly a decade of difficult returns and sluggish fundraising. The decision by the California Public Employees' Retirement System to largely abandon new commitments to venture funds will likely prolong the agony ... Read more
|
| Corporate Structure |
 The approach is well-suited to biotechs with technology to continually produce new drugs, Sokol said. The LLC conversion will help, among other benefits, create a more tax-efficient structure for passing on profits of asset sales to investors and employees than a C corp... Read more
|
| Pancreatic Cancer | |
Amgen Halts Pancreatic Cancer Drug Trial
The company said a board of medical experts recommended ending the trial because the drug, ganitumab, appears unlikely to help patient live longer. The company said there were no safety issues associated with the drug ... Read more
|
| EPO | |
Falling Epogen Sales Crash on Amgen's
Longmont, Colorado Plant
Falling sales of Amgen's anemia drug Epogen (EPO) have come home to roost in Longmont, CO, where the company will idle the facility where the drug is made in bulk. The plant will actually ramp up production over the next 12 to 15 months and then production will be halted, Peggy Krause, a local spokeswoman, tells the Longmont Times-Call. The plant will be idled and not shuttered so that it could be restarted if demand increases, Krause says .. Read more
|
| BioPartnering |
 The Pasadena-based Arrowhead announced that it entered into an agreement with Merck, through a subsidiary, to undertake an evaluation of a novel proprietary therapeutic monoclonal antibody candidate derived from Arrowhead's human-derived peptide targeting and discovery program ... Read more
|
| Up and Coming |
Stellar Biotechnologies Announces New C-Level Appointments
 The Port Hueneme-based Stellar Biotechnologies, Inc. announced that Herbert S. Chow, Ph.D. was appointed to the position of Chief Technology Officer (CTO) and Catherine Brisson, Ph.D. was appointed the position of Chief Pharmaceutical Officer (CPO) for the Company ... Read more
|
| Public Policy |
Battle Over Genetically Engineered Food
Heading to Voters
 A fight over genetically engineered foods has been heating up in the nation's grocery aisles. Now it's headed for the ballot box. Voters will soon decide whether to make California the first state in the country to require labels on products such as sweet corn whose genes have been altered to make them resistant to pests ... Read more at the LA Times
Your Opinion Matters to SoCalBio
Are you for or against labeling GM food?
Click here to vote
(voting is anonymous)
|
| SoCalBio Membership Saves You Money | |
Become a SoCalBio Member and save money through utlizing the SoCalBio Group Purchasing Program
Video Recap of SoCalBio Open House
|
| Jobs Available |
ChromLogic (Pasadena)
Holomic (Los Angeles)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
